Albertsson-Lindblad A, Palsdottir T, Smedby KE, Weibull CE, Glimelius I, Jerkeman M. Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017. haematol [Internet]. 2022Mar.1 [cited 2024Apr.20];107(3):740-3. Available from: https://haematologica.org/article/view/haematol.2021.279037